RLYB logo

Rallybio (RLYB) Company Overview

Profile

Full Name:

Rallybio Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 29, 2021

Indexes:

Not included

Description:

Rallybio is a biotechnology company focused on developing innovative therapies for rare diseases. They aim to address unmet medical needs by creating treatments that improve patients' lives. Their research emphasizes collaboration and advancing science to bring new solutions to the healthcare market.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 12, 25 HC Wainwright & Co.
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 22, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 30, 24 HC Wainwright & Co.
Buy
Oct 1, 24 HC Wainwright & Co.
Buy
Sep 3, 24 HC Wainwright & Co.
Buy
Aug 26, 24 Evercore ISI Group
Outperform
Aug 12, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Rallybio?
  • Does Rallybio pay dividends?
  • What sector is Rallybio in?
  • What industry is Rallybio in?
  • What country is Rallybio based in?
  • When did Rallybio go public?
  • Is Rallybio in the S&P 500?
  • Is Rallybio in the NASDAQ 100?
  • Is Rallybio in the Dow Jones?
  • When was Rallybio's last earnings report?
  • When does Rallybio report earnings?
  • Should I buy Rallybio stock now?

What is the ticker symbol for Rallybio?

The ticker symbol for Rallybio is NASDAQ:RLYB

Does Rallybio pay dividends?

No, Rallybio does not pay dividends

What sector is Rallybio in?

Rallybio is in the Healthcare sector

What industry is Rallybio in?

Rallybio is in the Biotechnology industry

What country is Rallybio based in?

Rallybio is headquartered in United States

When did Rallybio go public?

Rallybio's initial public offering (IPO) was on July 29, 2021

Is Rallybio in the S&P 500?

No, Rallybio is not included in the S&P 500 index

Is Rallybio in the NASDAQ 100?

No, Rallybio is not included in the NASDAQ 100 index

Is Rallybio in the Dow Jones?

No, Rallybio is not included in the Dow Jones index

When was Rallybio's last earnings report?

Rallybio's most recent earnings report was on Nov 7, 2024

When does Rallybio report earnings?

The next expected earnings date for Rallybio is Mar 12, 2025

Should I buy Rallybio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions